You have 9 free searches left this month | for more free features.

HRAS

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

Not yet recruiting
  • Advanced Solid Tumors
  • Cincinnati, Ohio
  • +2 more
Oct 22, 2023

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) Trial (Tipifarnib)

Available
  • HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
  • (no location specified)
Jun 7, 2022

Urothelial Carcinoma Trial in Seoul (tipifarnib)

Active, not recruiting
  • Urothelial Carcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

HRAS Gene Mutation, HNSCC Trial in Worldwide (Tipifarnib, HRAS Detection Assay)

Recruiting
  • HRAS Gene Mutation
  • HNSCC
  • Los Angeles, California
  • +131 more
Feb 24, 2021

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

Insulin Dependent Diabetes, Diabetes type2 Trial in Sirnak

Completed
  • Insulin Dependent Diabetes
  • Diabetes type2
    • Şirnak, Merkez, Turkey
      Şirnak Devlet Hastanesi
    Jun 22, 2023

    Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

    Recruiting
    • Advanced Solid Tumor (Phase 1)
    • +4 more
    • Duarte, California
    • +4 more
    Feb 2, 2023

    Gastric Cancer, Healthy Trial in Hangzhou (No intervention)

    Recruiting
    • Gastric Cancer
    • Healthy
    • No intervention
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Aug 7, 2023

    Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

    Not yet recruiting
    • Malignant Solid Neoplasm
    • +4 more
    • (no location specified)
    Nov 8, 2022

    NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • +3 more
    • Boston, Massachusetts
    • +9 more
    Dec 22, 2022

    ctDNA in Cancer Early Detection and STAS Evaluation in GGOs

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • cf DNA and ct DNA
    • Roma, Italy
      Thoracic Surgery Unit, Sapienza University of Rome
    Mar 31, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022

      Early Development of Endometrial Carcinoma

      Recruiting
      • Cancer of Endometrium
        • Ferrara, Italy
          Section of Obstetrics and Gynecology, Department of Morphology,
        Apr 4, 2022

        Testing Practices for Common Solid Cancers in Precision Oncology

        Active, not recruiting
        • Breast Carcinoma
        • +5 more
        • Survey Administration
        • Chicago, Illinois
          Center for Business Models in Healthcare
        Dec 29, 2021

        Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

        Not yet recruiting
        • Acute Lymphoblastic Leukemia, in Relapse
        • +4 more
        • Utrecht, Netherlands
          Princess Máxima Center for Pediatric Oncology
        Dec 13, 2022

        MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

        Recruiting
        • Myelodysplastic Syndromes
        • Next Generation Sequencing
        • +5 more
        • Innsbruck, Tyrol, Austria
          Medical University of Innsbruck
        Apr 6, 2022

        Soft Tissue Sarcoma Trial in France (drug, combination product, other)

        Recruiting
        • Soft Tissue Sarcoma
        • Bordeaux, France
        • +17 more
        Oct 4, 2022

        Hospitalism in Children Trial in Richmond (Animal-assisted interaction, Conversational interaction)

        Recruiting
        • Hospitalism in Children
        • Animal-assisted interaction
        • Conversational interaction
        • Richmond, Virginia
          Virginia Commonwealth University
        Jan 10, 2023

        Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

        Not yet recruiting
        • Advanced Malignant Solid Neoplasm
        • Locally Advanced Malignant Solid Neoplasm
        • (no location specified)
        Dec 2, 2022